Thus, these findings could suggest a therapeutic modulation of autophagy involving approaches that functionally target WIPI proteins and ATG5-ATG16 complex for the treatment of FTD and other diseases involving mutations in TDP-43 gene. The gene discussed is ATG5; the disease is frontotemporal dementia.